A. Woronoff, B. Trétarre, A. Guizard, P. Arveux, F. Binder-foucard et al., Col de l'utérus Estimation nationale de l'incidence et de la mortalité par cancer en France entre, 1980.

D. Vuyst, H. Clifford, G. Nascimento, M. Madeleine, M. Franceschi et al., Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis, International Journal of Cancer, vol.50, issue.7, pp.1626-1662, 2008.
DOI : 10.1155/2007/159137

A. Garnier and P. Brindel, Prévention et dépistage du cancer du col de l'utérus. Boulogne-Billancourt : Institut national du cancer

J. Cuzick, Overview of the European and North American studies on HPV testing in primary cervical cancer screening, International Journal of Cancer, vol.93, issue.5, pp.1095-101, 2006.
DOI : 10.1097/01.AOG.0000109426.82624.f8

A. Spence, Process of care failures in invasive cervical cancer: Systematic review and meta-analysis, Preventive Medicine, vol.45, issue.2-3, pp.93-106, 2007.
DOI : 10.1016/j.ypmed.2007.06.007

J. Boulanger, Histoire cytologique des??cancers du??col ut??rin diagnostiqu??s en??France en??2006, Gyn??cologie Obst??trique & Fertilit??, vol.35, issue.9, pp.764-71, 2007.
DOI : 10.1016/j.gyobfe.2007.07.019

N. Engl and J. Med, Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. FUTURE II Study Group, pp.1915-27301, 2007.

B. Donovan, N. Franklin, R. Guy, A. Grulich, D. Regan et al., Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data, The Lancet Infectious Diseases, vol.11, issue.1, pp.39-44, 2011.
DOI : 10.1016/S1473-3099(10)70225-5

T. Read, J. Hocking, M. Chen, B. Donovan, C. Bradshaw et al., The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme, Sexually Transmitted Infections, vol.87, issue.7, 2011.
DOI : 10.1136/sextrans-2011-050234

J. Brotherton, M. Fridman, C. May, G. Chappell, A. Saville et al., Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study, The Lancet, vol.377, issue.9783, pp.2085-92, 2011.
DOI : 10.1016/S0140-6736(11)60551-5

J. Br and . Cancer, Reduction of low-and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland, pp.1824-1854, 2014.

M. Saraiya and E. Unger, US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines, JNCI: Journal of the National Cancer Institute, vol.107, issue.6, 2015.
DOI : 10.1093/jnci/djv086

I. Heard, L. Tondeur, L. Arowas, M. Demazoin, M. Falguières et al., Human Papillomavirus Types Distribution in Organised Cervical Cancer Screening in France, PLoS ONE, vol.30, issue.11, p.79372, 2013.
DOI : 10.1371/journal.pone.0079372.t004

URL : https://hal.archives-ouvertes.fr/hal-01643641

L. Abramowitz, A. Jacquard, and F. Jaroud, Human papillomavirus genotype distribution in anal cancer in France: The EDiTH V study, International Journal of Cancer, vol.20, issue.Suppl 10, pp.433-439, 2011.
DOI : 10.1097/01.aids.0000253361.63578.14

URL : https://hal.archives-ouvertes.fr/hal-00563122

H. Conseil-de-santé-publique, Vaccinations des personnes immunodéprimées ou aspléniques Rapport Décembre, 2014.

H. Conseil-de-santé-publique, Avis relatif aux recommandations vaccinales contre les infections à papillomavirus humains chez les hommes, 2016.

G. Invs and A. Afssa, Evaluation des risques sanitaires liés à l'exposition de la population française à l'aluminium. Eaux, aliments, produits de santé Agence française de sécurité sanitaire des aliments, Agence française de sécurité sanitaire des produits de santé : Saint-Maurice, p.192, 2003.

R. Gherardi, M. Coquet, and P. Chérin, Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle, Brain, vol.124, issue.9, pp.1821-1831, 2001.
DOI : 10.1093/brain/124.9.1821

C. Siegrist, Les adjuvants vaccinaux et la myofasciite ?? macrophages, Archives de P??diatrie, vol.12, issue.1, pp.1511-1533, 2003.
DOI : 10.1016/j.arcped.2004.06.017

. Afssaps, Myofasciite à macrophages, vaccin, aluminium. in Groupe ad hoc du 13 octobre, 2010.

X. Bégué and P. , L'origine du refus des vaccinations. Science & pseudo-sciences, 2012.

H. Aluminium, . Vaccins, L. Fressard, and F. Collange, OBS5079/vaccins-nous-ne-savons-pas-grand- chose-sur-les-effets-de-l-aluminium Vaccine Hesitancy Among General Practitioners and Its Determinants During Controversies: A National Cross-sectional Survey in France, EBioMedicine, vol.2, pp.891-897, 2013.

A. Kerneis, C. Jacquet, and A. Bannay, on behalf of the EDUVAC Study Group. Vaccine education of medical students : a nationwide cross-sectionnal survey

R. Sur and L. Vaccination, Comité d'orientation de la concertation citoyenne sur la vaccination, 2016.